AustinPx Invests in Pharmaceutics and Manufacturing Capabilities to Accelerate Drug Development

GEORGETOWN, Texas--(BUSINESS WIRE)--AustinPx, a leading contract development and manufacturing organization (CDMO) specializing in bioavailability enhancement of orally delivered small molecule drug candidates, today announced its acquisition of a 3P Innovations API in capsule filling machine, a FT4 Powder Rheometer®, and the STYL’One Nano compaction simulator. The latest investments enhance AustinPx’s early phase development and manufacturing capabilities by enabling faster timelines, improved